Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06978127 · ClinicalTrials.gov registry record · NA
Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients
A NA study of Chronic Kidney Disease Requiring Hemodialysis, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 424
- Enrollment target
- 2
- Study locations
NCT06978127: Recruiting NA study of Chronic Kidney Disease Requiring Hemodialysis, sponsored by University of Pittsburgh.
NCT06978127 is a NA study of Chronic Kidney Disease Requiring Hemodialysis that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 424 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06978127, a NA study of Chronic Kidney Disease Requiring Hemodialysis, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 424 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this study is to learn if a collaborative care intervention of pharmaco-therapy and/or cognitive behavioral therapy (CBT), delivered in a real-world setting, improves symptoms of pain, fatigue and/or depression.
Primary Outcome
Change in fatigue is a primary outcome. The Functional Assessment of Chronic Illness Therapy Fatigue (FACIT-F) will be used to measure fatigue. Scores range from 0-52 with lower scores indicating greater fatigue.
Conditions Studied
Interventions
- BEHAVIORAL Technology Assisted Stepped Collaborative Care
- OTHER Usual Care Arm
Study Locations (2)
New Mexico
- UNM - Albuquerque
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 424 participants |
| Start Date | 2025-08-28 |
| Est. Completion | 2029-06-30 |
| Phase | NA |
What NCT06978127 shows while recruiting
NCT06978127 is an interventional study that assigns participants to a tested intervention. The registered 424 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower).
The record links to 1 condition, with Chronic Kidney Disease Requiring Hemodialysis appearing as the primary indexed condition, and to 2 interventions - of which Technology Assisted Stepped Collaborative Care is the first listed.
NCT06978127 reports a single indexed study location in New Mexico, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06978127 about?
NCT06978127 is a clinical study titled "Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients". The goal of this study is to learn if a collaborative care intervention of pharmaco-therapy and/or cognitive behavioral therapy (CBT), delivered in a real-world setting, improves symptoms of pain, fatigue and/or depression.
What is the current status of trial NCT06978127?
This trial is currently recruiting. It is a NA study. The enrollment target is 424 participants. The study started on 2025-08-28. Estimated completion is 2029-06-30.
What conditions does trial NCT06978127 study?
This clinical trial studies the following conditions: Chronic Kidney Disease Requiring Hemodialysis.
What interventions are being tested in trial NCT06978127?
The interventions under investigation include: Technology Assisted Stepped Collaborative Care (BEHAVIORAL), Usual Care Arm (OTHER).
Who is sponsoring clinical trial NCT06978127?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06978127 being conducted?
This trial has 2 study locations across New Mexico, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Disease Requiring Hemodialysis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06978127's enrollment target sits among peer trials
424 238th of 2000 higher than 1,763 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05632770 · 424 participants · NA
A Deployment Focused Pragmatic Trial of Optimal Stepped Care Intervention Targeting PTSD and Comorbidity for Acutely Hospitalized Injury Survivors Treated in US Trauma Care Systems
- NCT05733767 · 424 participants · Phase 2
Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study
- NCT07140913 · 424 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
- NCT07197827 · 424 participants · Phase 1
A Study of YL242 in Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI